As of yesterday, Rob Brainin, Executive Vice President and Chief Operating Officer, has been appointed as the company’s new Chief Executive Officer.
Data is at the heart of applicable genomics. As the volume and depth of genomic data grows, bioinformaticians are translating the data into interpretable patterns leading to new biological insight.
How can researchers determine the best path forward when so many studies are coming out, each with new information?
Google has announced a partnership with WuXi NextCODE, with the aim of enhancing its comprehensive genomics capabilities.
Designed to accelerate pre-clinical genomic research and drug discovery for the benefit of patients, the team behind the global genomic data marketplace has grown by nearly 50% in the past year.
Drugmakers are racing to secure health records and strike deals with technology companies, all to discover how medicines perform in the real world.
Researchers have developed a new method for sifting through genomic data in search of genetic variants that have helped populations adapt to their environments.
A USD $5 million technology prize aims to crack the origin of the genetic code. The Evolution 2.0 Prize was announced at Arizona State University in August 2017. The largest “origin of life” prize to date, it seeks to bridge the gap between chemistry, genomics and modern computing.
“I Would Like to See Widespread Reimbursement of Clinical Genomic Testing as Well as Screening” – Gavin Stone
Gavin Stone is an electronics engineer who joined Edico Genome in 2013 to lead corporate development and marketing for the DRAGEN™ Bio-IT Processor, the world’s first next-generation sequencing bioinformatics chip to massively speed up genomic medicine.
The technology used by Facebook, Google and Amazon to turn spoken language into text, recognize faces and target advertising could help doctors combat one of the deadliest killers in American hospitals.
DNAnexus launches new clinical trial solution that aims to streamline the incorporation of human genomic data into clinical trial designs.
As new technologies power the drive to achieve personalised health care, doctors may find it difficult to keep up with the pace of discovery. However, a recent collaboration between FDNA and the Manchester Centre for Genomic Medicine could soon change this.
Scientists have successfully mapped how genes are expressed differently in the brains of people with one of five major psychiatric disorders, providing a much needed deeper insight into how our genes influence our risk of developed mental illness, for the first time.